Experiences in the Prevention, Control and Elimination of Iodine Deficiency Disorders: a Regional Perspective
Overview
Affiliations
Before 1987, iodine deficiency was not considered an issue of major importance in the countries of the Eastern Mediterranean Region (EMR). Progress began with a systematic national study of goitre and other iodine deficiency disorders (IDD) in the Islamic Republic of Iran in 1983. Following a major review of the prevalence of IDD in member states, Guidelines for national programmes for the control of iodine deficiency disorders in the EMR were published by the World Health Organization (WHO) in 1988. This paper discusses progress towards elimination of iodine deficiency by reviewing the status of IDD in the countries of EMR and programmes for prevention and control of IDD with particular reference to the Islamic Republic of Iran, the first country to be declared IDD-free by WHO.
Sobhani S, Omidvar N, Abdollahi Z, Al Jawaldeh A Front Nutr. 2022; 8:789692.
PMID: 35004817 PMC: 8727882. DOI: 10.3389/fnut.2021.789692.
Talat A, Khan A, Nasreen S, Wass J Cureus. 2019; 11(9):e5661.
PMID: 31720137 PMC: 6823014. DOI: 10.7759/cureus.5661.
Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study.
Azizi F, Zadeh-Vakili A, Takyar M Int J Endocrinol Metab. 2018; 16(4 Suppl):e84777.
PMID: 30584442 PMC: 6289309. DOI: 10.5812/ijem.84777.
Haghpanah S, Jelodari S, Karamifar H, Saki F, Rahimi R, De Sanctis V Acta Biomed. 2018; 89(1):55-60.
PMID: 29633743 PMC: 6357611. DOI: 10.23750/abm.v89i1.5778.
Iodine deficiency status in the WHO Eastern Mediterranean Region: a systematic review.
Mohammadi M, Azizi F, Hedayati M Environ Geochem Health. 2017; 40(1):87-97.
PMID: 28224254 DOI: 10.1007/s10653-017-9911-z.